ENCell Co., Ltd. (KOSDAQ:456070)
South Korea · Delayed Price · Currency is KRW 8,600.00
-190.00 (-2.16%)
Jun 10, 2026, 3:30 PM KST
ENCell Market Cap
ENCell has a market cap or net worth of 94.85 billion as of June 10, 2026. Its market cap has decreased by -36.22% in one year.
Market Cap
94.85B
Enterprise Value
73.06B
Revenue
4.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,600.00
Market Cap Chart
Since August 23, 2024, ENCell's market cap has decreased from 160.82B to 94.85B, a decrease of -41.02%. That is a compound annual growth rate of -25.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 96.94B | -51.16% |
| Dec 30, 2025 | 198.50B | 7.25% |
| Dec 30, 2024 | 185.09B | 15.09% |
| Aug 23, 2024 | 160.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genexine | 129.16B |
| Macrogen | 124.57B |
| Vaxcell-Bio Therapeutics | 111.40B |
| MedPacto | 107.11B |
| Amicogen | 92.65B |
| GeneOne Life Science | 88.86B |
| iNtRON Biotechnology | 82.67B |
| Prestige BioPharma | 74.04B |